Clinical Pathologist

Job Description

Job Description

Salary : 250,000

Hematopathologist

HematoLogics, Inc. is a unique, research-driven hematopathology reference laboratory that is actively recruiting a Hematopathologist to join our team in our Seattle-based laboratory located on Elliott Bay. The successful candidate will collaborate with experienced pathologists, technical directors, clients, technicians, technologists and support staff to bring state of the art diagnostic and monitoring techniques to patients with hematologic malignancies. The ability to integrate multiple technologies including flow cytometry, cytogenetics, FISH, and molecular analysis, including NGS and RT-PCR, is essential.

There is wide variety in the disease entities encountered in our practice. This variety as well as the depth of the medical knowledge available within our team creates outstanding opportunities for professional growth and career development. In addition to possessing solid diagnostic skills, candidates who have an interest, previous training, and / or expertise in molecular genetics and flow cytometry are desirable. This would include junior candidates who intend to develop a career focused on hematopathology as well as mid-career candidates who have a proven clinical and academic track record. Both recent graduates and experienced pathologists are encouraged to apply.

Responsibilities include :

Primary flow cytometry analysis and pathology sign-out

Pathology sign-out of molecular diagnostic testing

Pathology sign-out of cytogenetic and FISH testing

Incorporate clinical pathological correlation in reports as needed.

Provide guidance and recommendations to laboratory personnel as needed.

Provide consultations for clients on testing triage, results interpretation, etc. as requested or needed.

Participate in the educational, clinical research, and developmental efforts of Hematologics, Inc

Provide consultations for fellow hematopathologists on cases as requested or needed.

Practice evidence-based medicine and drive innovation and discovery through a robust precision medicine program that is a proven leader in advanced cellular and genomic testing.

Qualifications :

MD, DO, MD / PhD or foreign equivalent with clinical pathology and hematopathology residency and fellowship training American Board of Pathology board certified / eligible in clinical pathology and hematopathology (either CP only or AP / CP)

Experience in pediatric hematopathology is desired

The successful candidate must possess excellent interpersonal skills and effectively interact with pathology colleagues, scientists clinicians, administrators, and laboratory staff.

Proven ability to work on multidisciplinary teams while exhibiting calm and professional behavior even during stressful situations and committing to fully engage in our collaborative team-centric approach

The ability to manage high-volume pathology sign-outs

High degree of care and attention to detail in performance of clinical duties with strict adherence to defined clinical testing protocols

Ability to independently manage ongoing projects as well as clinical work with meticulous attention to detail

The desire to change the practice of medicine by challenging current paradigms

Who We Are :

HematoLogics was founded over thirty years ago with the goal of assembling a group of physician / scientists who are passionate about applying advanced technologies for diagnosis and management of patients with hematologic disorders. We are at the forefront of medical diagnostics for hematologic malignancies and are pioneers in residual disease detection using Difference from Normal approach. We validated our approach for detection of residual disease in a hematopoietic stem cell transplant setting in collaboration with the Fred Hutchinson Cancer Center, where the diagnostic phenotype is not available. We extended our approach to myelodysplastic syndromes and initiated the European Leukemia Network MDS Working Group. Hematologics has shown that the amounts of gene products, throughout maturation from the hematopoietic stem cell to mature blood cells, are invariant from individual to individual. Disruption of this quantitative gene product expression is a hallmark of neoplastic transformation and allows for the detection of low levels of leukemia down to 0.02%. Hematologics is the reference laboratory for Childrens Oncology Group and the Leukemia Lymphoma Society AML studies and collaborates with clinicians at major universities not only in the US but worldwide with more than 125 scientific publications. Our unique expertise has created in international reputation as experts in lymphoid and myeloid neoplasms for pediatrics as well as adult patients with a special focus on patients with Down syndrome. Hematologics has routinely used cell sorting to enrich cell populations for chimerism testing post-transplant since 1998 and expanded the use of cell sorting starting in 2004 to improve the sensitivity of molecular and FISH assays.. The inter-disciplinary application, technical integration, and understanding of multiple technologies are the foundation for our exceptional service to our clients as well as ongoing learning opportunities for our team members.